Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial have?
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial has 849 citations in the OpenAlex counts ScholarIQ stores.
When was Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial published?
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial has 2000 year in the ScholarIQ index.
What is the open-access status of Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial?
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial has closed oa status in the ScholarIQ index.
What is the DOI of Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial?
The DOI for Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial is on the source record.
What is the PMID of Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial?
The PMID for Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial is on the source record.
What is the OpenAlex record for Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial?
The OpenAlex for Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial is on the source record.